通过抗疟疾药物氧化基因抑制短暂受体潜在瓦尼洛伊德3通道缓解了TRPV3依赖性皮肤炎
Beilei Zhang1, Bo Xie2, Wen Xu3
1Department of Dermatology, Hangzhou Third People's Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
The Journal of biological chemistry
|September 5, 2024
概括
抗疟疾药物氧化 (HCQ) 选择性地抑制TRPV3通道,为皮肤炎症提供了潜在的新疗法. 这项研究证明了HCQQ.
科学领域:
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
背景情况:
- 暂时受体潜在化物3 (TRPV3) 通道与皮肤炎症有关.
- 缺乏有效和特定的TRPV3抑制剂用于临床应用.
- 网络药理学预测了TRPV3抑制的潜在候选药物.
研究的目的:
- 为了识别和验证临时受体潜在化物3 (TRPV3) 通道的选择性抑制剂.
- 研究氧化 (HCQ) 作为皮肤炎症的TRPV3抑制剂的治疗潜力.
主要方法:
- 网络药理学分析用于候选药物预测.
- 全细胞补丁电生理学评估TRPV3通道抑制 (IC50,单通道活性).
- 分子对接和位点定向突变发生,以确定关键残留物.
- 在活体研究中,小鼠使用卡拉基南诱导的皮肤炎症模型.
主要成果:
- 基 (HCQ) 被确定为一种选择性TRPV3抑制剂,其IC50为51.69±4.78μM.
- HCQ降低了TRPV3通道的开放概率和单通道导电性;孔域残留是关键的.
- 在体内,HCQ改善了卡拉基南诱导的皮肤炎症,减少了表皮厚化,红和脱皮.
- 在背部皮肤组织中,HCQ治疗降低了血清免疫球蛋白E和炎症因子 (TNF-α,IL-6).
结论:
- 抗疟疾药物氧化 (HCQ) 是TRPV3通道的强效和选择性抑制剂.
- 在体外和体外,HCQ在减少皮肤炎症方面表现出显著的有效性.
- 通过向TRPV3.3,HCQ代表了一种有前途的治疗剂,用于管理炎症性皮肤疾病.
相关概念视频
T Cell Types and Functions
963
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
963
Thermosensation
30.3K
Peripheral thermosensation is the perception of external temperature. A change in temperature (on the surface of the skin and other tissues) is detected by a family of temperature-sensitive ion channels called Transient Receptor Potential, or TRP, receptors. These receptors are located on free nerve endings. Those detecting cold temperatures are closer to the surface of the skin than the nerve endings detecting warmth. These thermoTRP channels, while temperature selective, have relatively...
30.3K
Antihypertensive Drugs: Thiazide-Class Diuretics
563
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
563


